首页> 外国专利> METHOD FOR BLOOD MICROVESCILE LEVEL CORRECTION IN ARTERIAL HYPERTENSION, DYSLIPIDEMIA AND TYPE II DIABETES MELLITUS

METHOD FOR BLOOD MICROVESCILE LEVEL CORRECTION IN ARTERIAL HYPERTENSION, DYSLIPIDEMIA AND TYPE II DIABETES MELLITUS

机译:血管性高血压,血脂异常和II型糖尿病患者血液微囊水平矫正的方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to haematology, cardiology, endocrinology, and can be used for correction of the blood microvesicle level in the patients with arterial hypertension with dyslipidemia and type II diabetes mellitus. That is ensured by graduated physical exercises and the administration of Valsartan 80 mg once in the morning, Lovastatin 40 mg once a day in the evening at mealtimes and Metformin 500 mg twice a day. The length of treatment is at least 6 weeks.;EFFECT: method ensures reduced risk of thrombotic complications, higher clinical effectiveness and improved prognosis in the case patients due to the rating correction of the blood microvesicle level.;1 ex
机译:技术领域本发明涉及医学,即血液学,心脏病学,内分泌学,可用于纠正血脂异常和II型糖尿病的动脉高压患者的血液微囊泡水平。这是通过逐步进行体育锻炼和每天一次缬沙坦80毫克,洛伐他汀40毫克每天一次,进餐时间每天一次以及二甲双胍500毫克每天两次来确保的。治疗时间至少为6周。效果:由于血液微泡水平的等级校正,该方法可确保降低患者血栓形成并发症的风险,提高临床疗效并改善预后。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号